Principal Securities, Inc. Recursion Pharmaceuticals, Inc. Transaction History
Principal Securities, Inc.
- $4.44 Trillion
- Q4 2024
A detailed history of Principal Securities, Inc. transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Principal Securities, Inc. holds 1,318 shares of RXRX stock, worth $13,878. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,318
Previous 1,301
1.31%
Holding current value
$13,878
Previous $8.57 Million
3.92%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding RXRX
# of Institutions
331Shares Held
276MCall Options Held
2.53MPut Options Held
2.68M-
Vanguard Group Inc Valley Forge, PA34MShares$358 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl32.3MShares$341 Million1.91% of portfolio
-
Baillie Gifford & CO24.9MShares$262 Million0.13% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$182 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M014.7MShares$154 Million0.44% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.9B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...